<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">Moyamoya syndrome</z:e> is a <z:e sem="disease" ids="C0948441" disease_type="Disease or Syndrome" abbrv="VOD">vaso-occlusive disease</z:e> involving the intracranial vessels of the circle of Willis which is accompanied by an intense compensatory recruitment of new vessels </plain></SENT>
<SENT sid="1" pm="."><plain>Angiogenic substances such as basic fibroblast growth factor (bFGF) present in the cerebrospinal fluid (CSF) have been proposed as possible mediators of the neovascular response </plain></SENT>
<SENT sid="2" pm="."><plain>We analyzed CSF samples collected intraoperatively from predominantly pediatric patients with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e> and other conditions such as <z:hpo ids='HP_0002308'>Chiari malformation</z:hpo> (Ch), <z:hpo ids='HP_0002144'>tethered cord</z:hpo> (TC), <z:hpo ids='HP_0100026'>arteriovenous malformation</z:hpo> (<z:mp ids='MP_0006093'>AVM</z:mp>), <z:mp ids='MP_0009277'>brain tumor</z:mp> (BT) and <z:hpo ids='HP_0000238'>hydrocephalus</z:hpo> (HCP) </plain></SENT>
<SENT sid="3" pm="."><plain>We found that CSF bFGF was significantly elevated in patients with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e> (141 pg/ml, n = 37), Ch (56.7 pg/ml, n = 22), TC (55.1 pg/ml, n = 23), <z:mp ids='MP_0006093'>AVM</z:mp> (354 pg/ml, n = 5), and BT (208 pg/ml, n = 5) compared to patients with HCP (5.5 pg/ml, n = 7) and controls (1.6 pg/ml, n = 25; p &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>There was no dependence of CSF bFGF on patient age or gender </plain></SENT>
<SENT sid="5" pm="."><plain>Although CSF bFGF in the <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e> group showed no correlation with the Suzuki radiographic stage at either pre- or post-operative (1-year follow-up) angiography, it showed a trend with the Matsushima angiographic score with increasing collateral vascularization from the synangiosis developing at higher levels of CSF bFGF </plain></SENT>
<SENT sid="6" pm="."><plain>Our findings suggest that CSF bFGF may be playing a wide-ranging role in a number of central <z:mp ids='MP_0008912'>nervous</z:mp> system conditions associated with <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and hypervascularity </plain></SENT>
<SENT sid="7" pm="."><plain>Although not a specific marker for <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e>, elevated CSF bFGF may serve as a weak predictor of the extent of <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> to be expected in indirect revascularization procedures </plain></SENT>
</text></document>